1-(1-アダマンチル)エチルアミン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

  H315：皮膚刺激

  H319：強い眼刺激

  H335：呼吸器への刺激のおそれ

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P280：保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。

  P301+P312：飲み込んだ場合：気分が悪い時は医師に連絡する こと。

  P302+P352：皮膚に付着した場合：多量の水と石鹸で洗うこと。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

1-(1-アダマンチル)エチルアミン 価格

1-(1-アダマンチル)エチルアミン 化学特性,用途語,生産方法

• 効能

  抗ウイルス薬, M2タンパク阻害薬

• 使用

  Rimantadine act by blocking the M2 ion channel which is required for uptake of protons into the interior of the virus to permit acid-promoted viral uncoating (decapsidation).

• 一般的な説明

  Resistant variants of influenza type A have been recoveredfrom rimantadine-treated patients.Resistance with inhibitory concentrations increased morethan 100-fold have been associated with single nucleotidechanges that lead to amino acid substitutions in the transmembranedomain of M2. rimantadineshare cross-susceptibility and resistance.

• 応用例（製薬）

  An analog of amantadine, supplied as the hydrochloride for oral administration.

• 作用機序

  Rimantadine hydrochloride (α-methyl-1-adamantanemethylamine hydrochloride) is a synthetic adamatane derivative that is structurally and pharmacologically related to amantadine. It appears to be more effective than amantadine hydrochloride against influenza A, with fewer CNS side effects. Rimantadine hydrochloride is thought to interfere with virus uncoating by inhibiting the release of specific proteins. It may act by inhibiting RT or the synthesis of virus-specific RNA, but it does not inhibit virus adsorption or penetration. It appears to produce a virustatic effect early in the virus replication. It is used widely in Russia and Europe.

• 薬物動態学

  Oral absorption: >90%
  C_max 100 mg oral (every 12 h): 0.4–0.5 mg/L after 2–6 h
  Plasma half-life: c. 35 h
  Volume of distribution: Very large
  Plasma protein binding: c. 40%
  Absorption and distribution
  Single- and multiple-dose pharmacokinetic studies in elderly patients and young adults are remarkably similar. The steadystate concentration in nasal mucus develops by day 5 at a concentration approximately 1.5-fold higher than plasma.
  Metabolism
  In contrast to amantadine, rimantadine is extensively metabolized in the liver by hydroxylation and glucuronidation.
  Excretion
  Less than 20% is excreted unchanged in the urine and most of the breakdown products are excreted by this route. Thus, the plasma half-life is much less affected by renal dysfunction than that of amantadine.

• 臨床応用

  Prophylaxis and treatment of influenza A H1N1 infections Since prolonged administration is well tolerated by elderly patients, the drug is preferable to amantadine.

• 副作用

  Rimantadine has significantly fewer side effects than amantadine at equivalent doses, perhaps because of differences in pharmacokinetics, since with equal doses the blood levels are considerably lower. CNS side effects are not significantly higher than placebo.

1-(1-アダマンチル)エチルアミン 上流と下流の製品情報

1-(1-アダマンチル)エチルアミン 生産企業

Global(248)Suppliers

1-(1-アダマンチル)エチルアミン スペクトルデータ(MS)

13392-28-4, 1-(1-アダマンチル)エチルアミン キーワード